Literature DB >> 27569094

Correlations of magnetic resonance, perfusion-weighed imaging parameters and microvessel density in meningioma.

Ruihua Shi1, Tao Jiang, Lifang Si, Min Li.   

Abstract

PURPOSE: To investigate the correlations of magnetic resonance, perfusion-weighed imaging (PWI) parameters and microvessel density (MVD) in meningioma.
METHODS: 48 patients with pathologically confirmed meningioma (grade I, 38 cases; grade II+III, 10 cases) completed preoperative routine magnetic resonance imaging (MRI) and PWI. The cerebral blood volume (CBV) map of solid tumor region and the mean of maximum relative cerebral blood volume (rCBV) were then calculated. Immunohistochemical staining was performed in all specimens to measure the MVD.
RESULTS: On the CBV map, benign meningiomas showed a high perfusion signal, while malignant meningiomas exhibited a slightly higher one. The rCBV of benign meningiomas was 9.61±4.76, which was significantly higher than 3.61±0.25 of malignant meningiomas (t=7.165, p=0.000). The MVD of benign meningioma strips was 21.16 ± 11.32, which was also significantly higher than 10.71 ± 5.53 strips of malignant meningiomas (t=2.325, p=0.026). The correlation analysis showed that the mean of maximum rCBV and MVD of meningiomas had significant positive correlations (r=0.718, p=0.000).
CONCLUSIONS: The CBV map of benign meningiomas is different to that of malignant meningiomas, and the mean of maximum rCBV and MVD have significant positive correlations.

Entities:  

Mesh:

Year:  2016        PMID: 27569094

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  8 in total

1.  Characteristics of time-activity curves obtained from dynamic 11C-methionine PET in common primary brain tumors.

Authors:  Yuichi Nomura; Yoshitaka Asano; Jun Shinoda; Hirohito Yano; Yuka Ikegame; Tomohiro Kawasaki; Noriyuki Nakayama; Takashi Maruyama; Yoshihiro Muragaki; Toru Iwama
Journal:  J Neurooncol       Date:  2018-03-21       Impact factor: 4.130

2.  Evaluation of Magnetic Resonance Imaging for Microsurgical Efficacy and Relapse of Rolandic Meningioma.

Authors:  Peng Cao; Nianhua Wang
Journal:  Comput Intell Neurosci       Date:  2022-06-06

3.  Imaging and diagnostic advances for intracranial meningiomas.

Authors:  Raymond Y Huang; Wenya Linda Bi; Brent Griffith; Timothy J Kaufmann; Christian la Fougère; Nils Ole Schmidt; Jöerg C Tonn; Michael A Vogelbaum; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Ian F Dunn
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

4.  Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.

Authors:  M D Lee; G L Baird; L C Bell; C C Quarles; J L Boxerman
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

5.  Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas.

Authors:  Xin J Qiao; Hyun Grace Kim; Danny J J Wang; Noriko Salamon; Michael Linetsky; Ali Sepahdari; Benjamin M Ellingson; Whitney B Pope
Journal:  Eur J Radiol       Date:  2017-10-07       Impact factor: 3.528

6.  Relationship between Shear Stiffness Measured by MR Elastography and Perfusion Metrics Measured by Perfusion CT of Meningiomas.

Authors:  T Takamura; U Motosugi; M Ogiwara; Y Sasaki; K J Glaser; R L Ehman; H Kinouchi; H Onishi
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-13       Impact factor: 4.966

7.  Value of magnetic resonance diffusion combined with perfusion imaging techniques for diagnosing potentially malignant breast lesions.

Authors:  Hui Zhang; Xin-Yi Zhang; Yong Wang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

8.  Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports.

Authors:  Jason T Pham; Ronald C Kim; Anna Nguyen; Daniela Bota; Xiao-Tang Kong; Sumeet Vadera; Frank Hsu; Jose A Carrillo
Journal:  CNS Oncol       Date:  2018-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.